Senti Biosciences, INC. (SNTI) SEC Filings — 2024
19 SEC filings for Senti Biosciences, INC. (SNTI) in 2024.
Filings
- Senti Biosciences Files 8-K — 8-K · Dec 16, 2024
- NEA 15 Amends Senti Biosciences Stake — SC 13D/A · Dec 4, 2024
- Senti Biosciences Files 8-K — 8-K · Dec 3, 2024
- Senti Biosciences Files 8-K — 8-K · Dec 2, 2024
- Senti Biosciences Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Senti Biosciences Faces Delisting Notice — 8-K · Oct 25, 2024
- Senti Biosciences Enters Material Definitive Agreement — 8-K · Sep 27, 2024
- Senti Biosciences Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Senti Biosciences Files 8-K for Bylaw Amendments — 8-K · Jul 17, 2024
- Senti Biosciences Enters Material Definitive Agreement — 8-K · Jul 16, 2024
- Senti Biosciences Files 8-K on Security Holder Matters — 8-K · Jul 12, 2024
- Senti Biosciences Files Proxy Statement for July Meeting — DEF 14A · May 29, 2024
- Senti Biosciences Names New CEO, Board Changes — 8-K · May 17, 2024
- Senti Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Senti Bio Announces Leadership Changes — 8-K · May 2, 2024
- Senti Biosciences Files 10-K/A Amendment No. 1 for Fiscal Year Ended Dec 31, 2023 — 10-K/A · Apr 26, 2024
- Senti Biosciences, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- Senti Biosciences Faces Nasdaq Delisting for Low Bid Price — 8-K · Feb 6, 2024
- Senti Biosciences Reports Exit/Disposal Activities on Jan 3 — 8-K · Jan 5, 2024